XML 79 R36.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Restatement of the Consolidated Financial Statements (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2012
Text Block [Abstract] |
Adjustments to Previously Filed Consolidated Income Statements | The results of the adjustments to the Company’s previously filed consolidated statements of operations detailed above are summarized in the tables below. The tax effect of the adjustments is estimated based on the Company’s effective tax rate.
|  | Year Ended December 31, 2012 |
|  |  |  |  | Adjustments by Category |  |  |  |
(U.S. Dollars, in thousands) |  | Previously Reported |  |  | Distributor Revenue |  |  | Inventory Reserves |  |  | Royalties |  |  | Other |  |  | Total Adjustments |  |  | Restated |
Net sales |  | $ | 462,320 |  |  | $ | (14,777 | ) |  | $ | — |  |  | $ | — |  |  | $ | 38 |  |  | $ | (14,739 | ) |  | $ | 447,581 |
Cost of sales |  |  | 86,492 |  |  |  | (2,032 | ) |  |  | 5,647 |  |  |  | 8,190 |  |  |  | (44 | ) |  |  | 11,761 |  |  |  | 98,253 |
Gross profit |  |  | 375,828 |  |  |  | (12,745 | ) |  |  | (5,647 | ) |  |  | (8,190 | ) |  |  | 82 |  |  |  | (26,500 | ) |  |  | 349,328 |
Operating expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sales and marketing |  |  | 200,343 |  |  |  | (6,629 | ) |  |  | — |  |  |  | (8,190 | ) |  |  | 1,607 |  |  |  | (13,212 | ) |  |  | 187,131 |
General and administrative |  |  | 53,827 |  |  |  | (2 | ) |  |  | — |  |  |  | — |  |  |  | (434 | ) |  |  | (436 | ) |  |  | 53,391 |
Research and development |  |  | 28,577 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 28,577 |
Amortization of intangibles assets |  |  | 2,098 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 200 |  |  |  | 200 |  |  |  | 2,298 |
Charges related to U.S. Government resolutions |  |  | 1,973 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (678 | ) |  |  | (678 | ) |  |  | 1,295 |
|  |  | 286,818 |  |  |  | (6,631 | ) |  |  | — |  |  |  | (8,190 | ) |  |  | 695 |  |  |  | (14,126 | ) |  |  | 272,692 |
Operating income |  |  | 89,010 |  |  |  | (6,114 | ) |  |  | (5,647 | ) |  |  | — |  |  |  | (613 | ) |  |  | (12,374 | ) |  |  | 76,636 |
Other income and (expense) |  |  | (6,282 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (166 | ) |  |  | (166 | ) |  |  | (6,448 | )
Income before income taxes |  |  | 82,728 |  |  |  | (6,114 | ) |  |  | (5,647 | ) |  |  | — |  |  |  | (779 | ) |  |  | (12,540 | ) |  |  | 70,188 |
Income tax expense |  |  | (28,792 | ) |  |  | 1,782 |  |  |  | 1,645 |  |  |  | — |  |  |  | 227 |  |  |  | 3,654 |  |  |  | (25,138 | )
Net income from continuing operations, net of tax |  | $ | 53,936 |  |  | $ | (4,332 | ) |  | $ | (4,002 | ) |  | $ | — |  |  | $ | (552 | ) |  | $ | (8,886 | ) |  | $ | 45,050 |
|  | Year Ended December 31, 2011 |
|  |  |  |  | Adjustments by Category |  |  |  |
(U.S. Dollars, in thousands) |  | Previously Reported |  |  | Distributor Revenue |  |  | Inventory Reserves |  |  | Royalties |  |  | Other |  |  | Total Adjustments |  |  | Restated |
Net sales |  | $ | 470,121 |  |  | $ | (29,135 | ) |  | $ | — |  |  | $ | — |  |  | $ | 985 |  |  | $ | (28,150 | ) |  | $ | 441,971 |
Cost of sales |  |  | 92,619 |  |  |  | (8,289 | ) |  |  | 3,377 |  |  |  | 7,713 |  |  |  | 107 |  |  |  | 2,908 |  |  |  | 95,527 |
Gross profit |  |  | 377,502 |  |  |  | (20,846 | ) |  |  | (3,377 | ) |  |  | (7,713 | ) |  |  | 878 |  |  |  | (31,058 | ) |  |  | 346,444 |
Operating expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sales and marketing |  |  | 200,145 |  |  |  | (1,216 | ) |  |  | — |  |  |  | (7,713 | ) |  |  | 2,295 |  |  |  | (6,634 | ) |  |  | 193,511 |
General and administrative |  |  | 64,374 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 107 |  |  |  | 107 |  |  |  | 64,481 |
Research and development |  |  | 22,861 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 22,861 |
Amortization of intangibles assets |  |  | 2,350 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 200 |  |  |  | 200 |  |  |  | 2,550 |
Charges related to U.S. Government resolutions |  |  | 56,463 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 678 |  |  |  | 678 |  |  |  | 57,141 |
|  |  | 346,193 |  |  |  | (1,216 | ) |  |  | — |  |  |  | (7,713 | ) |  |  | 3,280 |  |  |  | (5,649 | ) |  |  | 340,544 |
Operating income |  |  | 31,309 |  |  |  | (19,630 | ) |  |  | (3,377 | ) |  |  | — |  |  |  | (2,402 | ) |  |  | (25,409 | ) |  |  | 5,900 |
Other income and (expense) |  |  | (11,868 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 3,915 |  |  |  | 3,915 |  |  |  | (7,953 | )
Income (loss) before income taxes |  |  | 19,441 |  |  |  | (19,630 | ) |  |  | (3,377 | ) |  |  | — |  |  |  | 1,513 |  |  |  | (21,494 | ) |  |  | (2,053 | )
Income tax expense |  |  | (21,181 | ) |  |  | 6,408 |  |  |  | 1,102 |  |  |  | — |  |  |  | (494 | ) |  |  | 7,016 |  |  |  | (14,165 | )
Net loss from continuing operations, net of tax |  | $ | (1,740 | ) |  | $ | (13,222 | ) |  | $ | (2,275 | ) |  | $ | — |  |  | $ | 1,019 |  |  | $ | (14,478 | ) |  | $ | (16,218 | )
|  | Year Ended December 31, 2010 |
|  |  |  |  | Adjustments by Category |  |  |  |
(U.S. Dollars, in thousands) |  | Previously Reported |  |  | Distributor Revenue |  |  | Inventory Reserves |  |  | Royalties |  |  | Other |  |  | Total Adjustments |  |  | Restated |
Net sales |  | $ | 460,629 |  |  | $ | 2,088 |  |  | $ | — |  |  | $ | — |  |  | $ | (146 | ) |  | $ | 1,942 |  |  | $ | 462,571 |
Cost of sales |  |  | 90,461 |  |  |  | (323 | ) |  |  | 2,281 |  |  |  | 5,386 |  |  |  | (712 | ) |  |  | 6,632 |  |  |  | 97,093 |
Gross profit |  |  | 370,168 |  |  |  | 2,411 |  |  |  | (2,281 | ) |  |  | (5,386 | ) |  |  | 566 |  |  |  | (4,690 | ) |  |  | 365,478 |
Operating expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sales and marketing |  |  | 200,835 |  |  |  | (275 | ) |  |  | — |  |  |  | (5,386 | ) |  |  | 939 |  |  |  | (4,722 | ) |  |  | 196,113 |
General and administrative |  |  | 72,912 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 98 |  |  |  | 98 |  |  |  | 73,010 |
Research and development |  |  | 27,958 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 27,958 |
Amortization of intangibles assets |  |  | 2,213 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 200 |  |  |  | 200 |  |  |  | 2,413 |
Charges related to U.S. Government resolutions |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
|  |  | 303,918 |  |  |  | (275 | ) |  |  | — |  |  |  | (5,386 | ) |  |  | 1,237 |  |  |  | (4,424 | ) |  |  | 299,494 |
Operating income |  |  | 66,250 |  |  |  | 2,686 |  |  |  | (2,281 | ) |  |  | — |  |  |  | (671 | ) |  |  | (266 | ) |  |  | 65,984 |
Other income and (expense) |  |  | (15,886 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 4,930 |  |  |  | 4,930 |  |  |  | (10,956 | )
Income before income taxes |  |  | 50,364 |  |  |  | 2,686 |  |  |  | (2,281 | ) |  |  | — |  |  |  | 4,259 |  |  |  | 4,664 |  |  |  | 55,028 |
Income tax expense |  |  | (22,606 | ) |  |  | (821 | ) |  |  | 697 |  |  |  | — |  |  |  | (1,301 | ) |  |  | (1,425 | ) |  |  | (24,031 | )
Net income from continuing operations, net of tax |  | $ | 27,758 |  |  | $ | 1,865 |  |  | $ | (1,584 | ) |  | $ | — |  |  | $ | 2,958 |  |  | $ | 3,239 |  |  | $ | 30,997 |
Effects of Restatements on Consolidated Balance Sheet | The effects of the restatements on the Company’s consolidated balance sheet as of December 31, 2012 are as follows:
|  | As of December 31, 2012 |
(U.S. Dollars, in thousands except share and per share data) |  | Previously Reported |  |  | Adjustments |  |  | Restated |
Assets |  |  |  |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 31,055 |  |  | $ | — |  |  | $ | 31,055 |
Restricted cash |  |  | 21,314 |  |  |  | — |  |  |  | 21,314 |
Trade accounts receivable, less allowances of $13,543 |  |  | 150,316 |  |  |  | (43,004 | ) |  |  | 107,312 |
Inventories |  |  | 88,744 |  |  |  | (5,371 | ) |  |  | 83,373 |
Deferred income taxes |  |  | 16,959 |  |  |  | 16,491 |  |  |  | 33,450 |
Escrow receivable |  |  | — |  |  |  | — |  |  |  | — |
Prepaid expenses and other current assets |  |  | 32,056 |  |  |  | 2,023 |  |  |  | 34,079 |
Assets held for sale |  |  | — |  |  |  | — |  |  |  | — |
Total current assets |  |  | 340,444 |  |  |  | (29,861 | ) |  |  | 310,583 |
Property, plant and equipment, net |  |  | 51,362 |  |  |  | 2,473 |  |  |  | 53,835 |
Patents and other intangible assets, net |  |  | 6,880 |  |  |  | 410 |  |  |  | 7,290 |
Goodwill |  |  | 74,388 |  |  |  | — |  |  |  | 74,388 |
Deferred income taxes |  |  | 19,904 |  |  |  | (1,023 | ) |  |  | 18,881 |
Other long-term assets |  |  | 11,303 |  |  |  | (3,383 | ) |  |  | 7,920 |
Total assets |  | $ | 504,281 |  |  | $ | (31,384 | ) |  | $ | 472,897 |
Liabilities and shareholders’ equity |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |  |  |
Bank borrowings |  | $ | 16 |  |  | $ | — |  |  | $ | 16 |
Current portion of long-term debt |  |  | — |  |  |  | — |  |  |  | — |
Trade accounts payable |  |  | 21,812 |  |  |  | 763 |  |  |  | 22,575 |
Accrued charges related to U.S. Government resolutions |  |  | — |  |  |  | — |  |  |  | — |
Other current liabilities |  |  | 46,969 |  |  |  | (7,375 | ) |  |  | 39,594 |
Liabilities held for sale |  |  | — |  |  |  | — |  |  |  | — |
Total current liabilities |  |  | 68,797 |  |  |  | (6,612 | ) |  |  | 62,185 |
Long-term debt |  |  | 20,000 |  |  |  | — |  |  |  | 20,000 |
Deferred income taxes |  |  | 11,456 |  |  |  | — |  |  |  | 11,456 |
Other long-term liabilities |  |  | 4,930 |  |  |  | 6,494 |  |  |  | 11,424 |
Total liabilities |  |  | 105,183 |  |  |  | (118 | ) |  |  | 105,065 |
Contingencies (Note 17) |  |  |  |  |  |  |  |  |  |  |  |
Shareholders’ equity |  |  |  |  |  |  |  |  |  |  |  |
Common shares $0.10 par value; 50,000,000 shares authorized; 19,339,329 issued and outstanding |  |  | 1,934 |  |  |  | — |  |  |  | 1,934 |
Additional paid-in capital |  |  | 246,111 |  |  |  | 195 |  |  |  | 246,306 |
Retained earnings |  |  | 148,549 |  |  |  | (33,702 | ) |  |  | 114,847 |
Accumulated other comprehensive income |  |  | 2,504 |  |  |  | 2,241 |  |  |  | 4,745 |
Total shareholders’ equity |  |  | 399,098 |  |  |  | (31,266 | ) |  |  | 367,832 |
Total liabilities and shareholders’ equity |  | $ | 504,281 |  |  | $ | (31,384 | ) |  | $ | 472,897 |
The effects of the restatements on the Company’s consolidated balance sheet as of December 31, 2011 are as follows:
|  | As of December 31, 2011 |
(U.S. Dollars, in thousands except share and per share data) |  | Previously Reported |  |  | Adjustments |  |  | Restated |
Assets |  |  |  |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 33,207 |  |  | $ | — |  |  | $ | 33,207 |
Restricted cash |  |  | 45,476 |  |  |  | — |  |  |  | 45,476 |
Trade accounts receivable, less allowances of $9,341 |  |  | 132,828 |  |  |  | (32,940 | ) |  |  | 99,888 |
Inventories |  |  | 82,969 |  |  |  | (1,441 | ) |  |  | 81,528 |
Deferred income taxes |  |  | 16,349 |  |  |  | 19,964 |  |  |  | 36,313 |
Escrow receivable |  |  | 41,537 |  |  |  | — |  |  |  | 41,537 |
Prepaid expenses and other current assets |  |  | 26,069 |  |  |  | (4,070 | ) |  |  | 21,999 |
Assets held for sale |  |  | 171,185 |  |  |  | — |  |  |  | 171,185 |
Total current assets |  |  | 549,620 |  |  |  | (18,487 | ) |  |  | 531,133 |
Property, plant and equipment, net |  |  | 43,368 |  |  |  | 2,769 |  |  |  | 46,137 |
Patents and other intangible assets, net |  |  | 8,236 |  |  |  | 610 |  |  |  | 8,846 |
Goodwill |  |  | 73,094 |  |  |  | — |  |  |  | 73,094 |
Deferred income taxes |  |  | 18,584 |  |  |  | (1,843 | ) |  |  | 16,741 |
Other long-term assets |  |  | 11,570 |  |  |  | (2,141 | ) |  |  | 9,429 |
Total assets |  | $ | 704,472 |  |  | $ | (19,092 | ) |  | $ | 685,380 |
Liabilities and shareholders’ equity |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |  |  |
Bank borrowings |  | $ | 1,318 |  |  | $ | — |  |  | $ | 1,318 |
Current portion of long-term debt |  |  | 17,500 |  |  |  | — |  |  |  | 17,500 |
Trade accounts payable |  |  | 16,488 |  |  |  | 1,743 |  |  |  | 18,231 |
Accrued charges related to U.S. Government resolutions |  |  | 82,500 |  |  |  | 638 |  |  |  | 83,138 |
Other current liabilities |  |  | 45,327 |  |  |  | (4,491 | ) |  |  | 40,836 |
Liabilities held for sale |  |  | 22,676 |  |  |  | — |  |  |  | 22,676 |
Total current liabilities |  |  | 185,809 |  |  |  | (2,110 | ) |  |  | 183,699 |
Long-term debt |  |  | 191,195 |  |  |  | — |  |  |  | 191,195 |
Deferred income taxes |  |  | 9,778 |  |  |  |  |  |  |  | 9,778 |
Other long-term liabilities |  |  | 2,519 |  |  |  | 6,115 |  |  |  | 8,634 |
Total liabilities |  |  | 389,301 |  |  |  | 4,005 |  |  |  | 393,306 |
Contingencies (Note 17) |  |  |  |  |  |  |  |  |  |  |  |
Shareholders’ equity |  |  |  |  |  |  |  |  |  |  |  |
Common shares $0.10 par value; 50,000,000 shares authorized; 18,465,444 issued and outstanding |  |  | 1,846 |  |  |  | — |  |  |  | 1,846 |
Additional paid-in capital |  |  | 214,310 |  |  |  | 195 |  |  |  | 214,505 |
Retained earnings |  |  | 97,254 |  |  |  | (25,245 | ) |  |  | 72,009 |
Accumulated other comprehensive income |  |  | 1,761 |  |  |  | 1,953 |  |  |  | 3,714 |
Total shareholders’ equity |  |  | 315,171 |  |  |  | (23,097 | ) |  |  | 292,074 |
Total liabilities and shareholders’ equity |  | $ | 704,472 |  |  | $ | (19,092 | ) |  | $ | 685,380 |
Effects of Restatements of Consolidated Statement of Operations and Comprehensive Income (Loss) | The effects of the restatements on the Company’s consolidated statement of operations and comprehensive income for the year ended December 31, 2012 are as follows:
|  | Year Ended December 31, 2012 |
(U.S. Dollars, in thousands, except share and per share data) |  | Previously Reported |  |  | Adjustments |  |  | Restated |
Product sales |  | $ | 415,850 |  |  |  | (14,811 | ) |  | $ | 401,039 |
Marketing service fees |  |  | 46,470 |  |  |  | 72 |  |  |  | 46,542 |
Net sales |  |  | 462,320 |  |  |  | (14,739 | ) |  |  | 447,581 |
Cost of sales |  |  | 86,492 |  |  |  | 11,761 |  |  |  | 98,253 |
Gross profit |  |  | 375,828 |  |  |  | (26,500 | ) |  |  | 349,328 |
Operating expenses |  |  |  |  |  |  |  |  |  |  |  |
Sales and marketing |  |  | 200,343 |  |  |  | (13,212 | ) |  |  | 187,131 |
General and administrative |  |  | 53,827 |  |  |  | (436 | ) |  |  | 53,391 |
Research and development |  |  | 28,577 |  |  |  | — |  |  |  | 28,577 |
Amortization of intangible assets |  |  | 2,098 |  |  |  | 200 |  |  |  | 2,298 |
Charges related to U.S. Government resolutions (Note 17) |  |  | 1,973 |  |  |  | (678 | ) |  |  | 1,295 |
|  |  | 286,818 |  |  |  | (14,126 | ) |  |  | 272,692 |
Operating income |  |  | 89,010 |  |  |  | (12,374 | ) |  |  | 76,636 |
Other income and (expense) |  |  |  |  |  |  |  |  |  |  |  |
Interest expense, net |  |  | (4,577 | ) |  |  | (166 | ) |  |  | (4,743 | )
Other expense |  |  | (1,705 | ) |  |  | — |  |  |  | (1,705 | )
|  |  | (6,282 | ) |  |  | (166 | ) |  |  | (6,448 | )
Income before income taxes |  |  | 82,728 |  |  |  | (12,540 | ) |  |  | 70,188 |
Income tax expense |  |  | (28,792 | ) |  |  | 3,654 |  |  |  | (25,138 | )
Net income from continuing operations, net of tax |  |  | 53,936 |  |  |  | (8,886 | ) |  |  | 45,050 |
Discontinued operations (Note 16) |  |  |  |  |  |  |  |  |  |  |  |
Gain on sale of Breg, Inc., net of tax |  |  | 1,345 |  |  |  | — |  |  |  | 1,345 |
Gain on sale of vascular operations, net of tax (Note 22) |  |  | — |  |  |  | — |  |  |  | — |
Loss from discontinued operations |  |  | (4,012 | ) |  |  | 1,018 |  |  |  | (2,994 | )
Income tax benefit (expense) |  |  | 26 |  |  |  | (589 | ) |  |  | (563 | )
Net loss from discontinued operations, net of tax |  |  | (2,641 | ) |  |  | 429 |  |  |  | (2,212 | )
Net income |  | $ | 51,295 |  |  |  | (8,457 | ) |  | $ | 42,838 |
Net income (loss) per common share—basic: |  |  |  |  |  |  |  |  |  |  |  |
Net income from continuing operations, net of tax |  | $ | 2.84 |  |  |  | (0.47 | ) |  | $ | 2.37 |
Net loss from discontinued operations, net of tax |  |  | (0.14 | ) |  |  | 0.02 |  |  |  | (0.12 | )
Net income per common share—basic |  | $ | 2.70 |  |  |  | (0.45 | ) |  | $ | 2.25 |
Net income (loss) per common share—diluted: |  |  |  |  |  |  |  |  |  |  |  |
Net income from continuing operations, net of tax |  | $ | 2.78 |  |  |  | (0.46 | ) |  | $ | 2.32 |
Net loss from discontinued operations, net of tax |  |  | (0.14 | ) |  |  | 0.03 |  |  |  | (0.11 | )
Net income per common share—diluted: |  | $ | 2.64 |  |  |  | (0.43 | ) |  | $ | 2.21 |
Weighted average number of common shares: |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | 18,977,263 |  |  |  | — |  |  |  | 18,977,263 |
Diluted |  |  | 19,390,413 |  |  |  | — |  |  |  | 19,390,413 |
Other comprehensive income, before tax: |  |  |  |  |  |  |  |  |  |  |  |
Translation adjustment |  | $ | 480 |  |  |  | 288 |  |  | $ | 768 |
Unrealized gain on derivative instrument |  |  | 416 |  |  |  | — |  |  |  | 416 |
Other comprehensive income, before tax |  |  | 896 |  |  |  | 288 |  |  |  | 1,184 |
Income tax expense related to components of other comprehensive income |  |  | (153 | ) |  |  | — |  |  |  | (153 | )
Other comprehensive income, net of tax |  |  | 743 |  |  |  | 288 |  |  |  | 1,031 |
Comprehensive income |  | $ | 52,038 |  |  |  | (8,169 | ) |  | $ | 43,869 |
The effects of the restatements on the Company’s consolidated statement of operations and comprehensive loss for the year ended December 31, 2011 are as follows:
|  | Year Ended December 31, 2011 |
(U.S. Dollars, in thousands, except share and per share data) |  | Previously Reported |  |  | Adjustments |  |  | Restated |
Product sales |  | $ | 432,975 |  |  |  | (27,828 | ) |  | $ | 405,147 |
Marketing service fees |  |  | 37,146 |  |  |  | (322 | ) |  |  | 36,824 |
Net sales |  |  | 470,121 |  |  |  | (28,150 | ) |  |  | 441,971 |
Cost of sales |  |  | 92,619 |  |  |  | 2,908 |  |  |  | 95,527 |
Gross profit |  |  | 377,502 |  |  |  | (31,058 | ) |  |  | 346,444 |
Operating expenses |  |  |  |  |  |  |  |  |  |  |  |
Sales and marketing |  |  | 200,145 |  |  |  | (6,634 | ) |  |  | 193,511 |
General and administrative |  |  | 64,374 |  |  |  | 107 |  |  |  | 64,481 |
Research and development |  |  | 22,861 |  |  |  | — |  |  |  | 22,861 |
Amortization of intangible assets |  |  | 2,350 |  |  |  | 200 |  |  |  | 2,550 |
Charges related to U.S. Government resolutions (Note 17) |  |  | 56,463 |  |  |  | 678 |  |  |  | 57,141 |
|  |  | 346,193 |  |  |  | (5,649 | ) |  |  | 340,544 |
Operating income |  |  | 31,309 |  |  |  | (25,409 | ) |  |  | 5,900 |
Other income and (expense) |  |  |  |  |  |  |  |  |  |  |  |
Interest expense, net |  |  | (9,456 | ) |  |  | 3,915 |  |  |  | (5,541 | )
Other expense |  |  | (2,412 | ) |  |  | — |  |  |  | (2,412 | )
|  |  | (11,868 | ) |  |  | 3,915 |  |  |  | (7,953 | )
Income (loss) before income taxes |  |  | 19,441 |  |  |  | (21,494 | ) |  |  | (2,053 | )
Income tax expense |  |  | (21,181 | ) |  |  | 7,016 |  |  |  | (14,165 | )
Net loss from continuing operations, net of tax |  |  | (1,740 | ) |  |  | (14,478 | ) |  |  | (16,218 | )
Discontinued operations (Note 16) |  |  |  |  |  |  |  |  |  |  |  |
Gain on sale of Breg, Inc., net of tax |  |  | — |  |  |  | — |  |  |  | — |
Gain on sale of vascular operations, net of tax (Note 22) |  |  | — |  |  |  | — |  |  |  | — |
Income (loss) from discontinued operations |  |  | 1,263 |  |  |  | (3,968 | ) |  |  | (2,705 | )
Income tax (expense) benefit |  |  | (596 | ) |  |  | 1,409 |  |  |  | 813 |
Net income (loss) from discontinued operations, net of tax |  |  | 667 |  |  |  | (2,559 | ) |  |  | (1,892 | )
Net loss |  | $ | (1,073 | ) |  |  | (17,037 | ) |  | $ | (18,110 | )
Net income (loss) per common share—basic: |  |  |  |  |  |  |  |  |  |  |  |
Net loss from continuing operations, net of tax |  | $ | (0.10 | ) |  |  | (0.79 | ) |  | $ | (0.89 | )
Net income (loss) from discontinued operations, net of tax |  |  | 0.04 |  |  |  | (0.14 | ) |  |  | (0.10 | )
Net loss per common share—basic |  | $ | (0.06 | ) |  |  | (0.93 | ) |  | $ | (0.99 | )
Net income (loss) per common share—diluted: |  |  |  |  |  |  |  |  |  |  |  |
Net loss from continuing operations, net of tax |  | $ | (0.10 | ) |  |  | (0.79 | ) |  | $ | (0.89 | )
Net income (loss) from discontinued operations, net of tax |  |  | 0.04 |  |  |  | (0.14 | ) |  |  | (0.10 | )
Net loss per common share—diluted: |  | $ | (0.06 | ) |  |  | (0.93 | ) |  | $ | (0.99 | )
Weighted average number of common shares: |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | 18,219,343 |  |  |  | — |  |  |  | 18,219,343 |
Diluted |  |  | 18,219,343 |  |  |  | — |  |  |  | 18,219,343 |
Other comprehensive loss, before tax: |  |  |  |  |  |  |  |  |  |  |  |
Translation adjustment |  | $ | (3,192 | ) |  |  | 913 |  |  | $ | (2,279 | )
Unrealized loss on derivative instrument |  |  | (693 | ) |  |  | — |  |  |  | (693 | )
Other comprehensive loss, before tax |  |  | (3,885 | ) |  |  | 913 |  |  |  | (2,972 | )
Income tax benefit related to components of other comprehensive income |  |  | 256 |  |  |  | — |  |  |  | 256 |
Other comprehensive loss, net of tax |  |  | (3,629 | ) |  |  | 913 |  |  |  | (2,716 | )
Comprehensive loss |  | $ | (4,702 | ) |  |  | (16,124 | ) |  | $ | (20,826 | )
The effects of the restatements on the Company’s consolidated statement of operations and comprehensive income for the year ended December 31, 2010 are as follows:
|  | Year Ended December 31, 2010 |
(U.S. Dollars, in thousands, except share and per share data) |  | Previously Reported |  |  | Adjustments |  |  | Restated |
Product sales |  | $ | 430,783 |  |  |  | 2,062 |  |  | $ | 432,845 |
Marketing service fees |  |  | 29,846 |  |  |  | (120 | ) |  |  | 29,726 |
Net sales |  |  | 460,629 |  |  |  | 1,942 |  |  |  | 462,571 |
Cost of sales |  |  | 90,461 |  |  |  | 6,632 |  |  |  | 97,093 |
Gross profit |  |  | 370,168 |  |  |  | (4,690 | ) |  |  | 365,478 |
Operating expenses |  |  |  |  |  |  |  |  |  |  |  |
Sales and marketing |  |  | 200,835 |  |  |  | (4,722 | ) |  |  | 196,113 |
General and administrative |  |  | 72,912 |  |  |  | 98 |  |  |  | 73,010 |
Research and development |  |  | 27,958 |  |  |  | — |  |  |  | 27,958 |
Amortization of intangible assets |  |  | 2,213 |  |  |  | 200 |  |  |  | 2,413 |
Charges related to U.S. Government resolutions (Note 17) |  |  | — |  |  |  | — |  |  |  | — |
|  |  | 303,918 |  |  |  | (4,424 | ) |  |  | 299,494 |
Operating income |  |  | 66,250 |  |  |  | (266 | ) |  |  | 65,984 |
Other income and (expense) |  |  |  |  |  |  |  |  |  |  |  |
Interest expense, net |  |  | (16,217 | ) |  |  | 4,930 |  |  |  | (11,287 | )
Other expense |  |  | 331 |  |  |  | — |  |  |  | 331 |
|  |  | (15,886 | ) |  |  | 4,930 |  |  |  | (10,956 | )
Income before income taxes |  |  | 50,364 |  |  |  | 4,664 |  |  |  | 55,028 |
Income tax expense |  |  | (22,606 | ) |  |  | (1,425 | ) |  |  | (24,031 | )
Net income from continuing operations, net of tax |  |  | 27,758 |  |  |  | 3,239 |  |  |  | 30,997 |
Discontinued operations (Note 16) |  |  |  |  |  |  |  |  |  |  |  |
Gain on sale of Breg, Inc., net of tax |  |  | — |  |  |  | — |  |  |  | — |
Gain on sale of vascular operations, net of tax (Note 22) |  |  | 12,019 |  |  |  | (3,498 | ) |  |  | 8,521 |
Income from discontinued operations |  |  | 10,015 |  |  |  | (4,926 | ) |  |  | 5,089 |
Income tax expense |  |  | (5,584 | ) |  |  | 5,273 |  |  |  | (311 | )
Net income from discontinued operations, net of tax |  |  | 16,450 |  |  |  | (3,151 | ) |  |  | 13,299 |
Net income |  | $ | 44,208 |  |  |  | 88 |  |  | $ | 44,296 |
Net income per common share—basic: |  |  |  |  |  |  |  |  |  |  |  |
Net income from continuing operations, net of tax |  | $ | 1.58 |  |  |  | 0.18 |  |  | $ | 1.76 |
Net income from discontinued operations, net of tax |  |  | 0.93 |  |  |  | (0.17 | ) |  |  | 0.76 |
Net income per common share—basic |  | $ | 2.51 |  |  |  | 0.01 |  |  | $ | 2.52 |
Net income per common share—diluted: |  |  |  |  |  |  |  |  |  |  |  |
Net income from continuing operations, net of tax |  | $ | 1.55 |  |  |  | 0.18 |  |  | $ | 1.73 |
Net income from discontinued operations, net of tax |  |  | 0.92 |  |  |  | (0.18 | ) |  |  | 0.74 |
Net income per common share—diluted: |  | $ | 2.47 |  |  |  | — |  |  | $ | 2.47 |
Weighted average number of common shares: |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | 17,601,956 |  |  |  | — |  |  |  | 17,601,956 |
Diluted |  |  | 17,913,545 |  |  |  | — |  |  |  | 17,913,545 |
Other comprehensive income (loss), before tax: |  |  |  |  |  |  |  |  |  |  |  |
Translation adjustment |  | $ | (1,710 | ) |  |  | 393 |  |  | $ | (1,317 | )
Unrealized loss on derivative instrument |  |  | (126 | ) |  |  | — |  |  |  | (126 | )
Other comprehensive loss, before tax |  |  | (1,836 | ) |  |  | 393 |  |  |  | (1,443 | )
Income tax benefit related to components of other comprehensive income |  |  | 36 |  |  |  | — |  |  |  | 36 |
Other comprehensive loss, net of tax |  |  | (1,800 | ) |  |  | 393 |  |  |  | (1,407 | )
Comprehensive income |  | $ | 42,408 |  |  |  | 481 |  |  | $ | 42,889 |

X
- Definition Restatement To Prior Year Consolidated Balance Sheet Table [Text Block] + References No definition available. + Details
Name: | ofix_RestatementToPriorYearConsolidatedBalanceSheetTableTextBlock
Namespace Prefix: | ofix_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Correcting Adjustments To Consolidated Income Table [Text Block] + References No definition available. + Details
Name: | ofix_ScheduleOfCorrectingAdjustmentsToConsolidatedIncomeTableTextBlock
Namespace Prefix: | ofix_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the nature and effects of a restatement to correct an error in the reported results of operations of prior periods. When prior period adjustments are recorded, the resulting effects (both gross and net of applicable income tax) on the net income of prior periods are disclosed in the annual report for the year in which the adjustments are made, and amended filings of previously issued reports are typically issued. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=6801783&loc=d3e22644-107794 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=6801783&loc=d3e22663-107794 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6801783&loc=d3e22658-107794 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 154 -Paragraph 25, 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Accounting Principles Board Opinion (APB) -Number 9 -Paragraph 26 -LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy. + Details
Name: | us-gaap_RestatementToPriorYearIncomeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_TextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration